Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05559892 · ClinicalTrials.gov registry record · NA

Conditional Cash Transfer Intervention to Improve T2DM

A NA study of Type 2 Diabetes, sponsored by State University of New York at Buffalo.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05559892: Active NA study of Type 2 Diabetes, sponsored by State University of New York at Buffalo.

NCT05559892 is a NA study of Type 2 Diabetes that is active but no longer recruiting, run by State University of New York at Buffalo. The registered enrollment target is 100 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05559892, a NA study of Type 2 Diabetes, is active but no longer recruiting, sponsored by State University of New York at Buffalo.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on clinical outcomes, self-care behaviors, and psychological health in 100 inner city AAs with poorly controlled T2DM using an RCT design. The aims of the proposed study include: AIM 1: Test the preliminary efficacy of the DM-CCT intervention on glycemic control and quality of life for inner-city AAs with T2DM. AIM 2: Test the preliminary efficacy of the DM-CCT intervention on self-care behaviors and psychological health for inner-city AAs with T2DM. AIM 3: Estimate the cost of delivery of the DM-CCT and UCT interventions in preparation for future cost effectiveness analysis.

Conditions Studied

Type 2 Diabetes

Interventions

  • BEHAVIORAL DM-CCT
  • BEHAVIORAL DM-UCT

Study Locations (1)

New York

  • State University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-11-01
Est. Completion 2026-11-30
Phase NA

Sponsor

State University of New York at Buffalo

243 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05559892

The ClinicalTrials.gov registry entry for NCT05559892 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (91% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which DM-CCT is the first listed.

NCT05559892 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05559892 about?

NCT05559892 is a clinical study titled "Conditional Cash Transfer Intervention to Improve T2DM". This study will test the preliminary efficacy of diabetes-tailored CCT (DM-CCT), which will be conditional on participating in biweekly (every two weeks), nurse-led, virtual diabetes education/skills training and stress/coping intervention compared to UCT (with no requirement for participation) on c...

What is the current status of trial NCT05559892?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-11-01. Estimated completion is 2026-11-30.

What conditions does trial NCT05559892 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05559892?

The interventions under investigation include: DM-CCT (BEHAVIORAL), DM-UCT (BEHAVIORAL).

Who is sponsoring clinical trial NCT05559892?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05559892 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.